Le Lézard
Classified in: Health
Subjects: CHI, SVY, TRI

BasicBites® Soft Chews Clinically Shown To Help Maintain Enamel Health in Children


ROSLYN HEIGHTS, N.Y., July 27, 2017 /PRNewswire/ -- Ortek Therapeutics, Inc. announced today that new data shows the effects of a novel sugar free chocolate soft chew in helping maintain enamel health in children. This product, BasicBites®, coats teeth with a vital blend of tooth supporting nutrients. BasicBites takes advantage of the mouth's natural protective processes to neutralize harmful sugar acids and enrich and fortify tooth enamel. The revolutionary technology in BasicBites was developed by renowned research scientists at Stony Brook University School of Dental Medicine. The 200 patient, double-blind, placebo-controlled study showed that eating two BasicBites a day was able to help maintain the health of molars in 6 to 11 year old children after one year compared to children in a placebo group.

Dental plaque on the surfaces of teeth contains billions of bacteria. Harmful bacteria convert sugars from foods and beverages to acids that over time can damage teeth. In an oral care breakthrough, scientists at Stony Brook University School of Dental Medicine discovered beneficial pH-raising oral bacteria also live on tooth surfaces. These researchers identified a vital nutrient that these "good" bacteria convert to enamel protecting buffers.

BasicBites coat teeth with a patented blend of nutrients ? arginine bicarbonate and calcium carbonate. Arginine is a common amino acid found in healthy saliva that is a favored source of nourishment for the beneficial bacteria discovered in dental plaque. These good bacteria convert the arginine in BasicBites into buffers that neutralize or counteract harmful plaque acids. Together, arginine and bicarbonate can help maintain a healthy oral pH (acid/base) balance on tooth enamel. Calcium is a mineral found in saliva and is an important substance for remineralization, a natural repair process for rebuilding and protecting tooth surfaces. BasicBites bathe teeth with a source of calcium in a favored oral pH environment that favors tooth remineralization. BasicBites are ideal for individuals with a sweet tooth, dry mouth or those concerned about their enamel health.

"We consider BasicBites to be one of the biggest breakthroughs in oral care," said Mitchell Goldberg, President, Ortek Therapeutics, Inc., the makers of BasicBites. "A large body of scientific studies have led to and continue to advance the development of the novel oral microbiome technology in BasicBites."

"We have extensively investigated the biochemistry and physiology of mixed bacterial communities in dental plaque and how they interact with saliva in supporting oral health," said Dr. Israel Kleinberg, DDS, PhD, DSc, Distinguished Professor in the Department of Oral Biology and Pathology and lead inventor of the technology in BasicBites. "Without killing or adding bacteria, BasicBites trigger the mouth's natural processes for protecting teeth."

BasicBites are 15 calories each and should be enjoyed twice daily, after breakfast and at bedtime. These delicious sugar free soft chews are recommended for children six and over, teens and even adults with dry mouth. BasicBites are available exclusively online. For more information and study results visit www.basicbites.com.

About Ortek Therapeutics, Inc. 

Ortek Therapeutics, Inc. is a global leader in developing and commercializing cutting edge oral and cutaneous microbiome technologies. Through its strategic alliance with the Research Foundation for the State University of New York, Ortek has developed major scientific advances in cavity prevention and detection as well as treatments for dentinal sensitivity. Ortek was founded in 1998.

SOURCE Ortek Therapeutics, Inc.


These press releases may also interest you

at 06:05
BeiGene, Ltd. , a global oncology company, today announced that the European Commission (EC) has approved tislelizumab as a treatment for non-small cell lung cancer (NSCLC) across three indications, including first- and second-line use....

at 06:05
Vizient, Inc. hosted its inaugural Insight: Cell, Gene, and Specialty Pharmacy Symposium, bringing together leading healthcare providers, payers and manufacturers of high-cost, ultra-specialty pharmaceuticals along with other stakeholders to discuss...

at 06:00
Panacea Healthcare Solutions,...

at 06:00
Orange County...

at 06:00
Imagine transforming your sauna experience into a precision tool for health optimization. High Tech Health International, Inc., a pioneer in infrared sauna technology, introduces Sauna Guidetm, an innovative technology poised to revolutionize sauna...

at 06:00
Danaher Corporation (the "Company") today announced results for the quarter ended March 29, 2024.  All results in this release reflect only continuing operations unless otherwise noted. Key First Quarter 2024 Results Net earnings were $1.1 billion,...



News published on and distributed by: